

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 9.89678808 |
| 2 | complement activation (GO:0006956) | 7.83841696 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.54314728 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.44857702 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.42021365 |
| 6 | positive regulation of respiratory burst (GO:0060267) | 6.18672204 |
| 7 | protein activation cascade (GO:0072376) | 5.69721208 |
| 8 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.41398060 |
| 9 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.41398060 |
| 10 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.41398060 |
| 11 | glomerular filtration (GO:0003094) | 5.40981639 |
| 12 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.38443171 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09716840 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.95424332 |
| 15 | renal filtration (GO:0097205) | 4.85453818 |
| 16 | type I interferon signaling pathway (GO:0060337) | 4.84839804 |
| 17 | cellular response to type I interferon (GO:0071357) | 4.84839804 |
| 18 | response to type I interferon (GO:0034340) | 4.82951300 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.82582448 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.82582448 |
| 21 | humoral immune response (GO:0006959) | 4.69799427 |
| 22 | detection of bacterium (GO:0016045) | 4.63573292 |
| 23 | regulation of respiratory burst (GO:0060263) | 4.59946427 |
| 24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.55430415 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51046332 |
| 26 | detection of other organism (GO:0098543) | 4.45392037 |
| 27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.26669546 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.19171164 |
| 29 | regulation of antigen processing and presentation (GO:0002577) | 3.99797397 |
| 30 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.88415673 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.86503812 |
| 32 | B cell mediated immunity (GO:0019724) | 3.82983754 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.82940781 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.76965091 |
| 35 | germinal center formation (GO:0002467) | 3.70051265 |
| 36 | antimicrobial humoral response (GO:0019730) | 3.68339112 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.60766401 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59173079 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59173079 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.59173079 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59173079 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.59173079 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59173079 |
| 44 | antibacterial humoral response (GO:0019731) | 3.58566881 |
| 45 | cellular response to interferon-gamma (GO:0071346) | 3.54652529 |
| 46 | retina homeostasis (GO:0001895) | 3.53693481 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.49802530 |
| 48 | regulation of cellular extravasation (GO:0002691) | 3.37873354 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.30431534 |
| 50 | response to interferon-gamma (GO:0034341) | 3.30253652 |
| 51 | negative regulation of myotube differentiation (GO:0010832) | 3.30137137 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.28219163 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23925064 |
| 54 | response to interferon-beta (GO:0035456) | 3.19519739 |
| 55 | myeloid dendritic cell differentiation (GO:0043011) | 3.11196770 |
| 56 | response to interferon-alpha (GO:0035455) | 3.04508366 |
| 57 | myeloid dendritic cell activation (GO:0001773) | 3.03131326 |
| 58 | respiratory burst (GO:0045730) | 3.01824002 |
| 59 | immune response-activating signal transduction (GO:0002757) | 3.01662753 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 2.97748470 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.95408778 |
| 62 | negative regulation of bone resorption (GO:0045779) | 2.94698314 |
| 63 | leukocyte aggregation (GO:0070486) | 2.94642358 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91921064 |
| 65 | negative regulation of innate immune response (GO:0045824) | 2.91855726 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.91103455 |
| 67 | activation of immune response (GO:0002253) | 2.88802266 |
| 68 | negative thymic T cell selection (GO:0045060) | 2.84959108 |
| 69 | regulation of B cell differentiation (GO:0045577) | 2.84697730 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81048222 |
| 71 | production of molecular mediator of immune response (GO:0002440) | 2.80988478 |
| 72 | T cell costimulation (GO:0031295) | 2.80854932 |
| 73 | dendritic cell chemotaxis (GO:0002407) | 2.79650815 |
| 74 | T cell migration (GO:0072678) | 2.79483282 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 2.79283556 |
| 76 | T-helper 1 type immune response (GO:0042088) | 2.79136922 |
| 77 | response to peptidoglycan (GO:0032494) | 2.78338464 |
| 78 | thymic T cell selection (GO:0045061) | 2.78089273 |
| 79 | lymphocyte costimulation (GO:0031294) | 2.76669757 |
| 80 | interferon-gamma secretion (GO:0072643) | 2.76498977 |
| 81 | detection of biotic stimulus (GO:0009595) | 2.75765728 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75482620 |
| 83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74828883 |
| 84 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.72248713 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71871903 |
| 86 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.70133650 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.69751830 |
| 88 | neutrophil activation involved in immune response (GO:0002283) | 2.68945701 |
| 89 | defense response to protozoan (GO:0042832) | 2.68580897 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.67392192 |
| 91 | negative T cell selection (GO:0043383) | 2.67232683 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.65614221 |
| 93 | B cell homeostasis (GO:0001782) | 2.65314886 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 2.64317877 |
| 95 | response to host immune response (GO:0052572) | 2.62945056 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62945056 |
| 97 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62892161 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57382678 |
| 99 | negative regulation of viral genome replication (GO:0045071) | 2.56097546 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.55332524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.79039993 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.87857801 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52570692 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.51752814 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.49662482 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.89324614 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84998912 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78597960 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.70307802 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48056439 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46748593 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46329619 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40305237 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.39235890 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.38361922 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36070024 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23886856 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16591473 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12168960 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11936250 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09571293 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.06170477 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03190496 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01157501 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00819899 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98593550 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.96727520 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90703732 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.88456115 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82147905 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80807602 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80418282 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77693711 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70424288 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69121145 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67974367 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.67166065 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62754547 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57851013 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52781574 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46401421 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45279222 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40370836 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37751551 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.35700234 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33821361 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.31519208 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30842305 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28991879 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26562302 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24572164 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24398119 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23945369 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23642496 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22921533 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22859042 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22419217 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18981019 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17967510 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16862428 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16432124 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16373307 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15410105 |
| 64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14042689 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13268904 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12966909 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12600996 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12499428 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11618979 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10414656 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09502100 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08581236 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07870450 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07510111 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06859763 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05546502 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04982094 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04839584 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02686286 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00762247 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00265004 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97423952 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97258607 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96343518 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96296589 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95434669 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95381416 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95161758 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94386153 |
| 90 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91691319 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91530368 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91467769 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91247910 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90967001 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90276722 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90185892 |
| 97 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87416511 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86565528 |
| 99 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85926371 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85496337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.04046172 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.89876580 |
| 3 | MP0003303_peritoneal_inflammation | 3.56463112 |
| 4 | MP0001790_abnormal_immune_system | 3.50301673 |
| 5 | MP0005387_immune_system_phenotype | 3.50301673 |
| 6 | MP0003436_decreased_susceptibility_to | 3.35483404 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.28023473 |
| 8 | MP0001800_abnormal_humoral_immune | 3.26841156 |
| 9 | MP0000685_abnormal_immune_system | 3.26451736 |
| 10 | MP0005671_abnormal_response_to | 2.93024991 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.83709702 |
| 12 | MP0005025_abnormal_response_to | 2.78854454 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.70519970 |
| 14 | MP0009785_altered_susceptibility_to | 2.70357322 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.53237714 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.48637814 |
| 17 | MP0002723_abnormal_immune_serum | 2.43499265 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.31912281 |
| 19 | MP0001819_abnormal_immune_cell | 2.30280590 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.20867734 |
| 21 | MP0002419_abnormal_innate_immunity | 2.17611957 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.15158673 |
| 23 | MP0001873_stomach_inflammation | 2.11929211 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.05506845 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.03384867 |
| 26 | MP0003866_abnormal_defecation | 1.92487342 |
| 27 | MP0004947_skin_inflammation | 1.92277567 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.90099394 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.83884828 |
| 30 | MP0006082_CNS_inflammation | 1.81312695 |
| 31 | MP0000716_abnormal_immune_system | 1.80712972 |
| 32 | MP0002398_abnormal_bone_marrow | 1.80637155 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.78929526 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.64812492 |
| 35 | MP0005310_abnormal_salivary_gland | 1.61486887 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.61105302 |
| 37 | MP0005275_abnormal_skin_tensile | 1.58154869 |
| 38 | MP0002405_respiratory_system_inflammati | 1.53757906 |
| 39 | MP0004264_abnormal_extraembryonic_tissu | 1.53140232 |
| 40 | MP0002429_abnormal_blood_cell | 1.45412774 |
| 41 | MP0005166_decreased_susceptibility_to | 1.43457627 |
| 42 | MP0000858_altered_metastatic_potential | 1.39041300 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.38858997 |
| 44 | MP0002006_tumorigenesis | 1.37741256 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.37551317 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.36085173 |
| 47 | MP0002722_abnormal_immune_system | 1.34161511 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.33751558 |
| 49 | MP0001663_abnormal_digestive_system | 1.33562242 |
| 50 | MP0003045_fibrosis | 1.28177342 |
| 51 | MP0008469_abnormal_protein_level | 1.21156616 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.13574809 |
| 53 | MP0000490_abnormal_crypts_of | 1.12615155 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.09229451 |
| 55 | MP0002796_impaired_skin_barrier | 1.08986550 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.05931523 |
| 57 | MP0003075_altered_response_to | 1.05233325 |
| 58 | MP0002933_joint_inflammation | 1.04935891 |
| 59 | MP0008004_abnormal_stomach_pH | 1.01128130 |
| 60 | MP0003448_altered_tumor_morphology | 1.00983743 |
| 61 | MP0001851_eye_inflammation | 0.99691718 |
| 62 | MP0000703_abnormal_thymus_morphology | 0.98861035 |
| 63 | MP0005023_abnormal_wound_healing | 0.95940167 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 0.95468923 |
| 65 | MP0000343_altered_response_to | 0.94267710 |
| 66 | MP0009764_decreased_sensitivity_to | 0.93813939 |
| 67 | MP0003828_pulmonary_edema | 0.93386997 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 0.92845397 |
| 69 | MP0009278_abnormal_bone_marrow | 0.92381161 |
| 70 | MP0005381_digestive/alimentary_phenotyp | 0.90446782 |
| 71 | MP0005390_skeleton_phenotype | 0.89889239 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 0.88102643 |
| 73 | MP0005451_abnormal_body_composition | 0.86869068 |
| 74 | MP0003091_abnormal_cell_migration | 0.86492608 |
| 75 | MP0000477_abnormal_intestine_morphology | 0.86023341 |
| 76 | MP0000249_abnormal_blood_vessel | 0.84897428 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.84820864 |
| 78 | MP0004510_myositis | 0.83377344 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.83189033 |
| 80 | MP0003252_abnormal_bile_duct | 0.74354259 |
| 81 | MP0008260_abnormal_autophagy | 0.73227114 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.73135684 |
| 83 | MP0004858_abnormal_nervous_system | 0.73023999 |
| 84 | MP0000604_amyloidosis | 0.72081542 |
| 85 | MP0002132_abnormal_respiratory_system | 0.71823470 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.70450466 |
| 87 | MP0005503_abnormal_tendon_morphology | 0.69535312 |
| 88 | MP0001216_abnormal_epidermal_layer | 0.67727550 |
| 89 | MP0009840_abnormal_foam_cell | 0.67605225 |
| 90 | MP0003795_abnormal_bone_structure | 0.66429823 |
| 91 | MP0005164_abnormal_response_to | 0.66220840 |
| 92 | MP0008874_decreased_physiological_sensi | 0.66176162 |
| 93 | MP0009763_increased_sensitivity_to | 0.65246575 |
| 94 | MP0010678_abnormal_skin_adnexa | 0.65065178 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.62997812 |
| 96 | MP0001542_abnormal_bone_strength | 0.61273671 |
| 97 | MP0009931_abnormal_skin_appearance | 0.60566011 |
| 98 | MP0005165_increased_susceptibility_to | 0.59209378 |
| 99 | MP0001853_heart_inflammation | 0.56480652 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.56414839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.32319834 |
| 2 | Abnormality of macrophages (HP:0004311) | 5.30480657 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.26113725 |
| 4 | Prostate neoplasm (HP:0100787) | 5.14105953 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 4.39383530 |
| 6 | Increased IgE level (HP:0003212) | 4.33438269 |
| 7 | Vasculitis (HP:0002633) | 4.29542105 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.17097935 |
| 9 | Agammaglobulinemia (HP:0004432) | 4.12466909 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.94689156 |
| 11 | Abnormality of the prostate (HP:0008775) | 3.92963686 |
| 12 | Meningitis (HP:0001287) | 3.88647263 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.71727100 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65870994 |
| 15 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.64853476 |
| 16 | Cellulitis (HP:0100658) | 3.55536428 |
| 17 | Malnutrition (HP:0004395) | 3.53242845 |
| 18 | Abnormality of complement system (HP:0005339) | 3.40647217 |
| 19 | Urticaria (HP:0001025) | 3.37874961 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.27002686 |
| 21 | Emphysema (HP:0002097) | 3.21309256 |
| 22 | Skin rash (HP:0000988) | 3.17442856 |
| 23 | Colitis (HP:0002583) | 3.17213190 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.17144179 |
| 25 | Myositis (HP:0100614) | 3.15781180 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11813764 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11594639 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.09733969 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.02196328 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.02176930 |
| 31 | Glomerulonephritis (HP:0000099) | 3.00615500 |
| 32 | Chronic otitis media (HP:0000389) | 2.99931200 |
| 33 | Obstructive lung disease (HP:0006536) | 2.99505724 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99505724 |
| 35 | Orchitis (HP:0100796) | 2.99149652 |
| 36 | Recurrent viral infections (HP:0004429) | 2.99047201 |
| 37 | Osteomyelitis (HP:0002754) | 2.96601900 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.96041087 |
| 39 | Complement deficiency (HP:0004431) | 2.94083426 |
| 40 | Premature loss of primary teeth (HP:0006323) | 2.88058032 |
| 41 | Gingivitis (HP:0000230) | 2.87864954 |
| 42 | Recurrent skin infections (HP:0001581) | 2.86353675 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.83897745 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.80838917 |
| 45 | IgM deficiency (HP:0002850) | 2.80470510 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78075082 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78075082 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.73244472 |
| 49 | Nephritis (HP:0000123) | 2.70498664 |
| 50 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.70493264 |
| 51 | Villous atrophy (HP:0011473) | 2.70493264 |
| 52 | Pustule (HP:0200039) | 2.69655915 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.69340708 |
| 54 | Leukocytosis (HP:0001974) | 2.68893950 |
| 55 | Lymphopenia (HP:0001888) | 2.67825475 |
| 56 | Abnormality of male internal genitalia (HP:0000022) | 2.67572889 |
| 57 | IgA deficiency (HP:0002720) | 2.64793459 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.64242497 |
| 59 | Optic neuritis (HP:0100653) | 2.63674215 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.63674215 |
| 61 | Bronchitis (HP:0012387) | 2.59789798 |
| 62 | Hemoptysis (HP:0002105) | 2.55573912 |
| 63 | Recurrent lower respiratory tract infections (HP:0002783) | 2.54981079 |
| 64 | Increased IgM level (HP:0003496) | 2.50160258 |
| 65 | Restrictive lung disease (HP:0002091) | 2.50145404 |
| 66 | Encephalitis (HP:0002383) | 2.49277041 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.46956302 |
| 68 | Hyperactive renin-angiotensin system (HP:0000841) | 2.45000025 |
| 69 | Skin ulcer (HP:0200042) | 2.42736341 |
| 70 | Chest pain (HP:0100749) | 2.40534354 |
| 71 | Nasal polyposis (HP:0100582) | 2.35813611 |
| 72 | Papilloma (HP:0012740) | 2.32408233 |
| 73 | Verrucae (HP:0200043) | 2.32408233 |
| 74 | Chronic diarrhea (HP:0002028) | 2.31560367 |
| 75 | Xerostomia (HP:0000217) | 2.26185457 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.23262123 |
| 77 | Sepsis (HP:0100806) | 2.22641055 |
| 78 | Abnormality of T cells (HP:0002843) | 2.18742098 |
| 79 | Keratoconjunctivitis sicca (HP:0001097) | 2.17685601 |
| 80 | Hypermelanotic macule (HP:0001034) | 2.17668153 |
| 81 | Viral hepatitis (HP:0006562) | 2.16616872 |
| 82 | Erythema (HP:0010783) | 2.16269401 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.15760391 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.15525798 |
| 85 | Abnormality of the pleura (HP:0002103) | 2.09627855 |
| 86 | Purpura (HP:0000979) | 2.08552452 |
| 87 | Alopecia of scalp (HP:0002293) | 1.98096623 |
| 88 | Arthralgia (HP:0002829) | 1.97467389 |
| 89 | Hypertensive crisis (HP:0100735) | 1.96889264 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.94639090 |
| 91 | Decreased circulating renin level (HP:0003351) | 1.94143113 |
| 92 | Keratoconjunctivitis (HP:0001096) | 1.93996222 |
| 93 | Abnormality of T cell number (HP:0011839) | 1.93313284 |
| 94 | Granulocytopenia (HP:0001913) | 1.93208374 |
| 95 | Neoplasm of the lung (HP:0100526) | 1.92228010 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 1.91293614 |
| 97 | Abnormality of B cell number (HP:0010975) | 1.91046617 |
| 98 | Palmoplantar hyperkeratosis (HP:0000972) | 1.88781963 |
| 99 | Flattened epiphyses (HP:0003071) | 1.88334002 |
| 100 | Epistaxis (HP:0000421) | 1.85601748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.38527000 |
| 2 | MAP4K1 | 5.13674291 |
| 3 | RIPK4 | 3.75249784 |
| 4 | TYK2 | 3.29395543 |
| 5 | PRPF4B | 3.18441762 |
| 6 | BLK | 2.66742397 |
| 7 | FGFR4 | 2.63498914 |
| 8 | SMG1 | 2.31311677 |
| 9 | IRAK4 | 2.24465903 |
| 10 | KIT | 2.18172872 |
| 11 | TBK1 | 2.11523308 |
| 12 | IKBKE | 2.05999617 |
| 13 | JAK1 | 1.97172555 |
| 14 | EPHB1 | 1.85930233 |
| 15 | CSF1R | 1.82517958 |
| 16 | MAP3K14 | 1.78838012 |
| 17 | MAP3K10 | 1.77064894 |
| 18 | SIK3 | 1.76593827 |
| 19 | CSK | 1.72897813 |
| 20 | RIPK1 | 1.69206140 |
| 21 | CDC42BPA | 1.66954605 |
| 22 | SYK | 1.65343903 |
| 23 | JAK3 | 1.65101394 |
| 24 | FES | 1.63847045 |
| 25 | EPHA3 | 1.58762407 |
| 26 | FGFR3 | 1.58212568 |
| 27 | MST1R | 1.50153479 |
| 28 | GRK6 | 1.49335522 |
| 29 | TRIB3 | 1.42523573 |
| 30 | LYN | 1.40098533 |
| 31 | BTK | 1.35051725 |
| 32 | ZAP70 | 1.31714015 |
| 33 | SIK2 | 1.20249963 |
| 34 | MAP3K1 | 1.13623559 |
| 35 | MATK | 1.12516079 |
| 36 | FGR | 1.11153777 |
| 37 | MAP3K13 | 1.09164835 |
| 38 | JAK2 | 1.06900938 |
| 39 | HCK | 1.05903287 |
| 40 | IKBKB | 1.02952187 |
| 41 | HIPK2 | 0.94733119 |
| 42 | TAOK1 | 0.94067879 |
| 43 | LRRK2 | 0.90371682 |
| 44 | LCK | 0.90235326 |
| 45 | MAPK7 | 0.89978061 |
| 46 | YES1 | 0.88377627 |
| 47 | TNK2 | 0.87581883 |
| 48 | TXK | 0.83951227 |
| 49 | STK24 | 0.83359144 |
| 50 | MAP3K3 | 0.82068612 |
| 51 | IRAK1 | 0.79352317 |
| 52 | PTK6 | 0.78528800 |
| 53 | MAP2K3 | 0.77350982 |
| 54 | PRKCQ | 0.74392563 |
| 55 | PIK3CA | 0.68324962 |
| 56 | PKN2 | 0.66649389 |
| 57 | MAPK11 | 0.63775870 |
| 58 | PRKCH | 0.61848889 |
| 59 | PDK1 | 0.61363908 |
| 60 | PRKD2 | 0.61045988 |
| 61 | MAP3K11 | 0.60930434 |
| 62 | ITK | 0.59996675 |
| 63 | NLK | 0.58254618 |
| 64 | BMPR2 | 0.57931865 |
| 65 | FYN | 0.55687466 |
| 66 | PDPK1 | 0.54314616 |
| 67 | TAOK3 | 0.54197931 |
| 68 | KSR2 | 0.54142717 |
| 69 | SIK1 | 0.53886470 |
| 70 | FER | 0.50715922 |
| 71 | DDR2 | 0.48393618 |
| 72 | MAPKAPK2 | 0.46064279 |
| 73 | TEC | 0.45547055 |
| 74 | RET | 0.44437802 |
| 75 | TAOK2 | 0.43464664 |
| 76 | EPHA2 | 0.42816222 |
| 77 | PRKCD | 0.42362339 |
| 78 | NEK9 | 0.41414099 |
| 79 | DMPK | 0.40408034 |
| 80 | STK10 | 0.39825949 |
| 81 | PRKG2 | 0.39620411 |
| 82 | CDK4 | 0.39423509 |
| 83 | TESK2 | 0.38254544 |
| 84 | OXSR1 | 0.37478297 |
| 85 | PRKCI | 0.37195341 |
| 86 | EPHB2 | 0.35957280 |
| 87 | CDK19 | 0.35786281 |
| 88 | CHUK | 0.35637676 |
| 89 | CDK12 | 0.34409656 |
| 90 | MAP3K2 | 0.30353340 |
| 91 | TGFBR1 | 0.30072076 |
| 92 | ABL1 | 0.29650119 |
| 93 | PDGFRA | 0.29431915 |
| 94 | CDK6 | 0.29333056 |
| 95 | MAPK12 | 0.28987180 |
| 96 | PDGFRB | 0.28540711 |
| 97 | MARK3 | 0.27242057 |
| 98 | TGFBR2 | 0.26511642 |
| 99 | MARK2 | 0.25969231 |
| 100 | CDK9 | 0.24316670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.90970521 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.90726985 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.81769555 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.69247811 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.65936321 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.60356046 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.97667099 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.92159290 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85108650 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.62070416 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.53447755 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.39666577 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13675816 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 1.82251556 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77586650 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73403457 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67874022 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.64667090 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58478048 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53432663 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.43270032 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41042506 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36933828 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.36380838 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24826146 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23786735 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.23053224 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22677479 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.21184363 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20829449 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.19568724 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16075275 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.14011506 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12237187 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00633090 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96580423 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92224048 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86594144 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84983802 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83725958 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81920235 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81398112 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.79735504 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.76857985 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76384952 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76114515 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72855641 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70398880 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68879554 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67979964 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67940399 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66420604 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63483886 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63123019 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61801265 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59549452 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57362387 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51788743 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.50671874 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49739725 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48253380 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.47861039 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.47396114 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44502472 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.42760640 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41729731 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39680412 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.39023504 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38792189 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38341596 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37936507 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.36687384 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36467778 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36011415 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36000485 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35609299 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34463493 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33392510 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32727466 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32074060 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.30386957 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30195824 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30033896 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.28958084 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28750741 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27950743 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26678539 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.26173869 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26146316 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.24841411 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24648673 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24638876 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.23215909 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.21963302 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20709240 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16978458 |
| 97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16388069 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15856440 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.15168240 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15115387 |

